Skip to main content
OpenTrials
Completed

NCT Number: NCT04405336

Tab Block and Patient Controlled Analgesia in CS

cesarean section rate become increasing nowadays

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–42 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Aljazeera( Al Gazeera) hospital

Giza, Egypt

About this study

indication of cesarean section are different from case to case and the use of pain controlling agents is very important to relieve post operative pain

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women coming for an elective CS

Exclusion criteria

  • women who has a n emergency CS or complicated normal deivery needs urgent CS

Treatment and study plan

tab block

Drug

injection of tab block to women who are doing cs

PCA

Drug

giving women PCA

women who will not receive tab block or PCA

Drug

no tab block or PCA will be given

Primary outcomes

  1. The number of women who will feel less pain post CS

    Time frame: 2 days

    the degree of pain that will be felt post CS

Sponsors and collaborators

Lead sponsor

Aljazeera Hospital

Other

Registry information

Official study title

Effect of Tab Block and Patient Controlled Analgesia in Cesarean Section

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
May 28, 2020
Registry last updated
May 25, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.